I. Introduction
Calcium ions have important role in pathophysiology of epilepsy. [1] A decrease in extracellular calcium concentration prior to onset of seizure activity is followed by an increase in the intracellular calcium concentration. [1] Generally, it is thought that the blockade of high voltage activated (L, N, P/Q type) calcium channels are associated with control of partial seizures with or without secondary generalization. [2] Calcium channel antagonists readily penetrating into the brain potentiated the protective efficacy of some antiepileptic drugs in both preclinical and clinical studies. Several reports have revealed beneficial effects of some calcium channel antagonists (flunarizine, cinnarizine and nimodipine) as add-on treatment in epileptic patients. [3] [4] [5] [6] [7] A reduced release of excitatory transmitters, including glutamate, is one of the consequences of calcium channel blockade. [8] Considering the fact that seizure activity depends on calcium ion and some antiepileptic drugs interfere with calcium ion fluxes, we attempted to study the effects of amlodipine, a dihydropyridine type calcium channel antagonist on the protective activity of lamotrigine, gabapentin, topiramate & carbamazepine in the rats by pentylenetetrazole (PTZ)and Maximal electroshock seizure(MES) induced seizure model.
II. Materials & Methods
The study was conducted on healthy adult albino wistar rats (150-250gm) of either sex. They were housed in the departmental animal house, in cages, in temperature regulated rooms with air cooling and 12 hour light and dark cycle, under standard laboratory conditions and fed with standard animal feed and were given water ad libitum. They were allowed to acclimatize to the laboratory conditions for a period of one week. The experiment protocol was approved by the Institutional animal ethics committee and was executed according to the guidelines of Committee for the purpose of control and supervision on experiment on animals (CPCSEA), India. Two hundred forty adult wistar rats divided into 40 groups in 6 each.
Pentylenetetrazole induced convulsion model
PTZ model induces seizure which resembles human absence seizure. PTZ was given at a dose of 40mg/kg after pretreatment with the medications. Animals were observed for 60 min. The onset, duration and number of seizures within 60 min were assessed to determine anticonvulsant action. The drugs were administered according to Table 1 . o to the plane of the body axis). The maximal electroshock is induced through ear electrode. A 50 Hz stimulus of 0.2 seconds duration was applied through saline wet ear electrodes. The current that produced convulsions with tonic hind limb extension was 150mA. This current was used throughout the study. The anticonvulsant activity of lamotrigine, gabapentin, topiramate and carbamazepine co-administered with amlodipine, as described in Table 2 , was evaluated by their respective onset and duration of THLE. 
Statistical analysis
Data were entered in Graph Pad Prism version 6.0 and analyzed using one way ANOVA followed by the post-hoc Bonferroni test for multiple comparisons. Differences among values were considered statistically significant if p < 0.05. Intraperitoneal administration of amlodipine produced a significant anticonvulsant effect against control in PTZ induced seizures in rats. Amlodipine in a dose-dependent manner, increased the latency and decreased the duration of seizure significantly at all doses of it (0.25, 0.5 and 1mg/kg) as depicted in Fig. 1 . Decreased number of seizures was found with highest dose amlodipine(1mg/kg). Intraperitoneal inj. of amlodipine at doses of 0.25, 0.5 and 1mg/kg (120 min before electro shock) was given to groups 22, 23 and 24 respectively. The low dose has not showed any significant change in onset and duration of seizure in MES model whereas medium and high dose have showed some anticonvulsant effect as shown in Fig. 6 . 
III. Results

Table3-Effect of amlodipine, anticonvulsants and their combinations on onset, duration and number of seizures in PTZ model
Effect of Amlodipine on the Antiepileptic Action of Lamotrigine
IV. Discussion
The present study was designed to assess the effect of amlodipine on the anticonvulsant action of lamotrigine, gabapentin, topiramate and a conventional anticonvulsant carbamazepine against PTZ and MES seizure models in rats. It was found that amlodipine alone (upto 0.25mg/kg) did not affect the electroconvulsive threshold in rats and this finding is partially in agreement with those documented earlier by Kaminski et al. 1999 . [9] Stefani et al showed amlodipine at dose of 0.5mg/kg potentiated the anticonvulsant action of carbamazepine in MES induced seizure. [10] In the present study, amlodipine at all the three doses significantly enhanced the anticonvulsant action of lamotrigine, gabapentin, topiramate and carbamazepine in both seizure models in rats. [10] To explain the interaction between lamotrigine and amlodipine against seizure, one should consider molecular mechanisms of action of both drugs. As regarding the anticonvulsant effect of lamotrigine, it has been documented that the drug acts at voltage-dependent sodium channels to decrease the presynaptic release of the excitatory neurotransmitter glutamate. [10] Moreover, lamotrigine decreases voltage-gated calcium currents and this effect, probably, contributes to a decrease in glutamate release. [10] On the other hand, experimental evidence indicates that N-type calcium channels are responsible for glutamate release in the cerebral cortex and hippocampus. [11] Apart from L-type, amlodipine blocks N-and P/Q-type calcium channels showing high affinity for both these channels. [12, 13] We can assume that amlodipine through the blockade of N-and P/Q-type calcium channels enhances the effect of lamotrigine related to the reduction of glutamate release from neurons. This hypothesis can readily explain the observed interaction between lamotrigine and amlodipine in both the seizure models in rats.
Regarding the anti-epileptic effect of gabapentin, the present study is supported by the findings of Mclean (1995) who studied the effect of gabapentin on the MES animal models. [14] The author reported that gabapentin was as potent as phenytoin and this is explained by the possibility of enhancing the ratio of gammaamino butyric acid(GABA) and glutamate, ion-channel actions and/ or enhancement of non synaptic GABA DOI: 10.9790/0853-150766573 www.iosrjournals.org 72 | Page release. [15] [16] [17] The favorable interaction between gabapentin and amlodipine in the MES model may be due to gabapentin increases the release of several monoamine neurotransmitters (e.g. norepinephrine) and inhibits glutamate synthesis by branched-chain amino acid aminotransferase. [18] It also may modulate calcium channels. [19] Topiramate is an antiepileptic drug sharing multiple mechanisms of action. This antiepileptic drug inhibits voltage-dependent sodium and L-type calcium channels, potentiates GABA mediated inhibitory neurotransmission through binding to a novel site on the GABA-A receptor complex and reduces excitatory neurotransmission by blocking α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and kainate subtypes of glutamate receptors. [20] [21] [22] Its effect on calcium channels may explain the interaction with amlodipine. [20] Carbamazepine at therapeutically relevant concentrations, reduce high frequency repetitive firing of neurons by an action on sodium channels & enhance potassium currents. [23] It is reported by Kaminski R et al that, calcium channel blockers increase the free plasma concentration of carbamazepine and thus increases the anticonvulsant activity. [9] V. Conclusion
Amlodipine potentiates the anticonvulsant action of lamotrigine, gabapentin, topiramate and carbamazepine in a dose dependent manner. Amlodipine alone showed anticonvulsant action at high doses. If the results from this study can be extrapolated to the clinical settings, a novel therapeutic option in the management of epilepsy might be created, where it could be used as adjunct in epileptic patients treated with lamotrigine, gabapentin, topiramate or carbamazepine who additionally required a calcium channel antagonist treatment for other than epilepsy reasons.
